EvolveImmune Therapeutics’ Post

At EvolveImmune, we focus on one of the primary therapeutic challenges in cancer. Does this align with your passion for cancer research? We have an opening for an Associate Director, Biotherapeutics. Join us! #careeropportunities #immunotherapy #Antibodies #Biotherapeutics #EvolveImmuneTherapeutics We’re #hiring. Know anyone who might be interested?

Thank you to all of the EvolveImmune team members that stepped in, rolled up their sleeves, and volunteered their time at Dan Cosgrove Animal Shelter located in our community of Branford, CT. #EvolveImmune #Teamworkinaction #AnimalRescue #ActsofService

Happy National Intern Day!!! Anousha Shahid, Claire Banks, Dylan Hegedus, Jeremy Wilson, Jonathan Estrada-Perez, Miles Bagoly, Shreeganesh Venkatesh and all of the past and future Interns of EvolveImmune: Your hard work, passion, fresh perspectives, and commitment to learn inspire us. As future leaders of the industry, your contributions have a significant impact and help advance EvolveImmune's efforts to pioneering a new class of precision cancer medicines. Keep shining and continue working towards Transformative Outcomes!!! #NationalInternDay #EvolveImmune #TeamworkInAction #GrowthandDevelopment

Join our team here at EvolveImmune Therapeutics!

Last week we celebrated our semi-annual cultural potluck luncheon. 35 delicious dishes ….. 35 powerful stories shared of their origins and meaning. #FoodPromotesTeamwork #EvolveImmune

The sun was shining and the ideas were flowing at beautiful University of Oxford as we evaluated the advantages of immune synapse formation induced by integrated CD2 costimulation with our EVOLVE technology. Thank you #MikeDustin, #ShangpanZhang and colleagues for such energizing and thoughtful discussions. #ForPatients #CD2Costimulation #JeremyMyers

Great presentation at the Antibody Engineering & Therapeutics Europe conference by Jeremy Myers describing the insights that led to the optimization of our EVOLVE technology and the potential therapeutic advantages of integrated CD2 costimulation. Our lead program EV-104 marches onward toward the clinic! #ForPatients #CD2Costimulation #EVOLVE